CONTINENTAL STRATEGY, LLC

Lobbying for NRX PHARMACEUTICALS · Clinical biopharma company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Delaware · $40,323.00 income · posted Oct 20, 2025

Lobbying activity 1

Pharmacy

Issues regarding lifesaving treatments

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem